Breaking News

Jubilant HollisterStier Site Approved for Lantheus Products

February 11, 2013

Will manufacture and supply DEFINITY, Cardiolite and Neurolite

The FDA has granted approval of Lantheus Medical Imaging’s sNDA, allowing Jubilant HollisterStier (JHS) to be a new manufacturing site for its ultrasound imaging agent, DEFINITY Vial for (Perflutren Liquid Microsphere) Injectable Suspension.
“FDA approval of JHS as a new manufacturer for DEFINITY is a major step forward in providing consistent and reliable supply to our customers,” said Jeff Bailey, Lantheus president and chief executive officer. “Supply chain diversification is a significant priority for the company as we work to ensure long-term product availability to meet market demand. We remain dedicated to providing the highest quality products to our customers and the patients they serve.”
DEFINITY is currently manufactured by Ben Venue Laboratories in Bedford, OH. In August 2011, Ben Venue announced plans to exit the contract manufacturing services business, which will take place during the next several years. In February 2012, Lantheus entered into a manufacturing and supply agreement with JHS for DEFINITY, as well as the manufacture and supply of Cardiolite and Neurolite, which are also manufactured by Ben Venue.
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks